Malignant Gliomas Clinical Trial
Official title:
Efficacy and Safety of Salvage Treatment With Dose-dense TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas: a Multicentre,Prospective Clinical Study
Temozolomide is the standard adjuvant chemotherapy of newly-diagnosis malignant
gliomas.Cisplatin , a kind of chemotherapeutics, can enforce the anti-tumor effects of TMZ.
Up to now, the prognosis of recurrent gliomas is very pessimistic and the standard treatment
procedure has not been established yet.
The prospective,multicentre phase II clinical study is to evaluate the efficacy and safety
of TMZ and CDDP in patients with recurrent malignant gliomas
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03212742 -
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01657734 -
Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy
|
N/A | |
| Completed |
NCT00165477 -
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
|
Phase 2 | |
| Completed |
NCT00879437 -
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
|
Phase 2 | |
| Completed |
NCT02632370 -
5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor
|
||
| Completed |
NCT02155452 -
Fluorescence and Glioma Heterogeneity
|
||
| Completed |
NCT00590954 -
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
|
Phase 2 | |
| Completed |
NCT00822887 -
Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas
|
Phase 1 | |
| Terminated |
NCT00923117 -
Sunitinib to Treat Recurrent Brain Cancer
|
Phase 2 | |
| Completed |
NCT02731521 -
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
|
||
| Completed |
NCT02388659 -
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
|
||
| Terminated |
NCT01549392 -
Imaging Study of Glioblastomas Treated With Avastin
|
N/A | |
| Completed |
NCT00272350 -
ZD6474 to Treat Advanced Brain Cancer in Patients
|
Phase 1 | |
| Completed |
NCT00271609 -
Bevacizumab for Recurrent Malignant Glioma
|
Phase 2 | |
| Completed |
NCT00074646 -
Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
|
Phase 1 | |
| Completed |
NCT00704080 -
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
|
Phase 1 | |
| Completed |
NCT00463073 -
Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas
|
Phase 2 | |
| Terminated |
NCT00671801 -
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I
|
Phase 1 | |
| Withdrawn |
NCT02369367 -
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme (Phase II)
|
Phase 2 |